• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to 'Pregnancy and liver health: delivering new collaborations to advance the MASLD and MASH field'.

作者信息

Allen Alina M, Lazarus Jeffrey V

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

City University of New York Graduate School of Public Health & Health Policy (CUNY SPH), New York City, NY, USA.

出版信息

Nat Rev Gastroenterol Hepatol. 2025 Jun 27. doi: 10.1038/s41575-025-01095-3.

DOI:10.1038/s41575-025-01095-3
PMID:40579474
Abstract
摘要

相似文献

1
Reply to 'Pregnancy and liver health: delivering new collaborations to advance the MASLD and MASH field'.对《妊娠与肝脏健康：推动新合作以促进代谢相关脂肪性肝病和代谢相关脂肪性肝炎领域发展》的回复
Nat Rev Gastroenterol Hepatol. 2025 Jun 27. doi: 10.1038/s41575-025-01095-3.
2
Pregnancy and liver health: delivering new collaborations to advance the MASLD and MASH field.妊娠与肝脏健康：开展新合作以推动代谢相关脂肪性肝病和代谢相关脂肪性肝炎领域的发展
Nat Rev Gastroenterol Hepatol. 2025 Jun 27. doi: 10.1038/s41575-025-01094-4.
3
Plain language summary about GLP-1 treatments in people with metabolic dysfunction-associated steatotic liver disease.关于胰高血糖素样肽-1（GLP-1）治疗代谢功能障碍相关脂肪性肝病患者的通俗易懂总结。
Postgrad Med. 2025 Jul 30:1-7. doi: 10.1080/00325481.2025.2537617.
4
Evaluation of Serum L-FABP as a Biomarker and Hepatoprotective Effect of L-FABP Using Wild-Type and Human L-FABP Chromosome Transgenic Mice.使用野生型和人L-FABP染色体转基因小鼠评估血清L-FABP作为生物标志物的作用及L-FABP的肝脏保护作用。
J Am Assoc Lab Anim Sci. 2025 May 1:1-10. doi: 10.30802/AALAS-JAALAS-25-003.
5
Envisioning how to advance the MASH field.展望如何推动 MASH 领域的发展。
Nat Rev Gastroenterol Hepatol. 2024 Oct;21(10):726-738. doi: 10.1038/s41575-024-00938-9. Epub 2024 Jun 4.
6
Disparities for Hispanic Adults With Metabolic Dysfunction-associated Steatotic Liver Disease in the United States: A Systematic Review and Meta-analysis.美国西班牙裔成人代谢功能障碍相关脂肪性肝病的差异：一项系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2025 Feb;23(2):236-249. doi: 10.1016/j.cgh.2024.06.038. Epub 2024 Jul 16.
7
A robust diagnostic model for high-risk MASH: integrating clinical parameters and circulating biomarkers through a multi-omics approach.一种用于高危暴发性肝衰竭的强大诊断模型：通过多组学方法整合临床参数和循环生物标志物。
Hepatol Int. 2025 Apr 9. doi: 10.1007/s12072-025-10792-9.
8
Effectiveness and safety of the SREBP1/2 inhibitor, fatostatin, in a preclinical model of metabolic dysfunction-associated steatotic liver disease progression.SREBP1/2抑制剂法托他汀在代谢功能障碍相关脂肪性肝病进展临床前模型中的有效性和安全性。
Eur J Pharmacol. 2025 Sep 15;1003:177890. doi: 10.1016/j.ejphar.2025.177890. Epub 2025 Jul 3.
9
A Comparison of the Predictive Value of 12 Body Composition Markers for Metabolic Dysfunction-Associated Steatotic Liver Disease, At-Risk Metabolic Dysfunction-Associated Steatohepatitis, and Increased Liver Stiffness in a General Population Setting.12种身体成分标志物对一般人群中代谢功能障碍相关脂肪性肝病、高危代谢功能障碍相关脂肪性肝炎及肝脏硬度增加的预测价值比较
Am J Gastroenterol. 2025 Jul 23. doi: 10.14309/ajg.0000000000003657.
10
MASLD Complicated By Diabetes: Pathophysiology and Emerging Therapies.合并糖尿病的代谢相关脂肪性肝病：病理生理学与新兴疗法
J Obes Metab Syndr. 2025 Jun 20. doi: 10.7570/jomes25017.

本文引用的文献

1
Pregnancy and liver health: delivering new collaborations to advance the MASLD and MASH field.妊娠与肝脏健康：开展新合作以推动代谢相关脂肪性肝病和代谢相关脂肪性肝炎领域的发展
Nat Rev Gastroenterol Hepatol. 2025 Jun 27. doi: 10.1038/s41575-025-01094-4.
2
Metabolic dysfunction-associated steatotic liver disease in adults.成人代谢功能障碍相关脂肪性肝病
Nat Rev Dis Primers. 2025 Mar 6;11(1):14. doi: 10.1038/s41572-025-00599-1.
3
Envisioning how to advance the MASH field.展望如何推动 MASH 领域的发展。
Nat Rev Gastroenterol Hepatol. 2024 Oct;21(10):726-738. doi: 10.1038/s41575-024-00938-9. Epub 2024 Jun 4.
4
A global research priority agenda to advance public health responses to fatty liver disease.推进应对脂肪肝疾病的公共卫生措施的全球研究优先事项议程
J Hepatol. 2023 Sep;79(3):618-634. doi: 10.1016/j.jhep.2023.04.035. Epub 2023 Jun 20.
5
OPTN/SRTR 2021 Annual Data Report: Liver.OPTN/SRTR 2021 年度数据报告：肝脏。
Am J Transplant. 2023 Feb;23(2 Suppl 1):S178-S263. doi: 10.1016/j.ajt.2023.02.006.
6
It is time to expand the fatty liver disease community of practice.是时候扩大脂肪肝疾病实践社群了。
Hepatology. 2023 Nov 1;78(5):1325-1328. doi: 10.1097/HEP.0000000000000411. Epub 2023 Jun 23.
7
Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases.生殖健康与肝脏疾病：美国肝病研究协会实践指南
Hepatology. 2021 Jan;73(1):318-365. doi: 10.1002/hep.31559. Epub 2021 Jan 3.
8
Review article: the management of cirrhosis in women.综述文章：女性肝硬化的管理
Aliment Pharmacol Ther. 2014 Nov;40(10):1146-54. doi: 10.1111/apt.12974. Epub 2014 Sep 28.